Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiography, Thoracic | 5 | 2015 | 1302 | 0.820 |
Why?
|
Mandatory Reporting | 1 | 2015 | 123 | 0.450 |
Why?
|
Hip Injuries | 1 | 2013 | 79 | 0.430 |
Why?
|
Thoracic Neoplasms | 1 | 2015 | 267 | 0.420 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2013 | 101 | 0.420 |
Why?
|
Brachiocephalic Veins | 1 | 2011 | 21 | 0.390 |
Why?
|
Professional-Family Relations | 1 | 2015 | 495 | 0.380 |
Why?
|
Pediatrics | 3 | 2015 | 3589 | 0.350 |
Why?
|
Vascular Neoplasms | 1 | 2011 | 166 | 0.340 |
Why?
|
Joint Diseases | 1 | 2013 | 459 | 0.340 |
Why?
|
Ultrasonography, Prenatal | 1 | 2015 | 1755 | 0.280 |
Why?
|
Hip Joint | 1 | 2013 | 1014 | 0.280 |
Why?
|
Tomography, X-Ray Computed | 6 | 2015 | 20568 | 0.270 |
Why?
|
Radiation Dosage | 1 | 2015 | 1958 | 0.270 |
Why?
|
Guideline Adherence | 1 | 2015 | 2220 | 0.240 |
Why?
|
Image Enhancement | 1 | 2015 | 2884 | 0.230 |
Why?
|
Referral and Consultation | 1 | 2015 | 3600 | 0.200 |
Why?
|
Ultrasonography | 1 | 2015 | 5971 | 0.200 |
Why?
|
Radiology | 1 | 2015 | 2113 | 0.190 |
Why?
|
Parents | 1 | 2015 | 3563 | 0.190 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1405 | 0.190 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3530 | 0.170 |
Why?
|
Angiography | 2 | 2013 | 1595 | 0.140 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2013 | 1222 | 0.130 |
Why?
|
Physician-Patient Relations | 1 | 2009 | 3251 | 0.130 |
Why?
|
Ferrosoferric Oxide | 1 | 2015 | 348 | 0.120 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2013 | 141 | 0.100 |
Why?
|
Physicians | 1 | 2009 | 4591 | 0.090 |
Why?
|
California | 1 | 2015 | 1430 | 0.090 |
Why?
|
Phlebography | 1 | 2011 | 326 | 0.090 |
Why?
|
Respiration Disorders | 1 | 2013 | 367 | 0.080 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 1682 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 1 | 2015 | 1432 | 0.080 |
Why?
|
Humanism | 1 | 2009 | 86 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36426 | 0.070 |
Why?
|
Drug and Narcotic Control | 1 | 2008 | 144 | 0.070 |
Why?
|
Phantoms, Imaging | 1 | 2015 | 2526 | 0.070 |
Why?
|
Anesthesia, General | 1 | 2013 | 1174 | 0.060 |
Why?
|
Cystic Fibrosis | 1 | 2013 | 1285 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2015 | 26202 | 0.060 |
Why?
|
Artifacts | 1 | 2013 | 1911 | 0.060 |
Why?
|
Heart Rate | 1 | 2015 | 4195 | 0.060 |
Why?
|
Government Regulation | 1 | 2008 | 524 | 0.050 |
Why?
|
Lung Diseases | 1 | 2013 | 1909 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2015 | 20100 | 0.050 |
Why?
|
Patients | 1 | 2009 | 907 | 0.050 |
Why?
|
Drug Approval | 1 | 2008 | 814 | 0.050 |
Why?
|
Child, Preschool | 5 | 2015 | 42232 | 0.050 |
Why?
|
Adolescent | 5 | 2015 | 88326 | 0.040 |
Why?
|
Anxiety | 1 | 2015 | 4573 | 0.040 |
Why?
|
Blood Pressure | 1 | 2015 | 8481 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12973 | 0.040 |
Why?
|
United States Food and Drug Administration | 1 | 2008 | 1664 | 0.040 |
Why?
|
Biopsy | 1 | 2011 | 6766 | 0.040 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2567 | 0.040 |
Why?
|
Infant | 3 | 2015 | 36193 | 0.040 |
Why?
|
Humans | 11 | 2015 | 761596 | 0.040 |
Why?
|
Contrast Media | 3 | 2015 | 5307 | 0.030 |
Why?
|
Male | 7 | 2015 | 360846 | 0.030 |
Why?
|
Anticoagulants | 1 | 2011 | 4812 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15843 | 0.030 |
Why?
|
Child | 5 | 2015 | 80158 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 6484 | 0.030 |
Why?
|
Off-Label Use | 1 | 2015 | 185 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2015 | 1379 | 0.030 |
Why?
|
Female | 6 | 2015 | 392705 | 0.020 |
Why?
|
Adult | 3 | 2015 | 221210 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11742 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1574 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14665 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2015 | 80647 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2606 | 0.020 |
Why?
|
Movement | 1 | 2013 | 1478 | 0.020 |
Why?
|
Wakefulness | 1 | 2013 | 1265 | 0.020 |
Why?
|
Drug Labeling | 1 | 2008 | 248 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2011 | 64685 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2015 | 5247 | 0.010 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2008 | 452 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6228 | 0.010 |
Why?
|
Drug Industry | 1 | 2008 | 788 | 0.010 |
Why?
|
Middle Aged | 1 | 2015 | 220921 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13255 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 59260 | 0.000 |
Why?
|
Time Factors | 1 | 2008 | 39969 | 0.000 |
Why?
|
United States | 1 | 2008 | 72340 | 0.000 |
Why?
|
Concepts
(85)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_